نتائج البحث - "Fjording, MS"

المؤلفون: Cowan KJ; Merck KGaA, New Biological Entities Drug Metabolism & Pharmacokinetics, Darmstadt, 64293, Germany., Golob M; Nuvisan GmbH, Bioanalysis, Neu-Ulm, 89231, Germany., Goodman J; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, CB21 6GH, UK., Laurén A; Novo Nordisk A/S, Non-clinical & Clinical Assay Sciences, Global Discovery & Development Sciences, Global Drug Discovery, Maløv, DK-2760, Denmark., Andersen L; Lundbeck A/S, Experimental Medicine & Clinical Development, Valby, DK-2500, Denmark representing Orphazyme A/S, Clinical Development, Copenhagen N, DK-2200, Denmark., Decker P; Argenx BV, Bioanalytics, Zwijnaarde, 9052, Belgium., Dejager L; UCB Pharma, Development Science, Translational Biomarkers & Bioanalysis, Chemin du Foriest, Braine-l'Alleud, B-1420, Belgium., Fjording MS; BioAgilytix Labs, Lademannbogen 10, Hamburg, 22339, Germany., Groenen P; Idorsia Pharmaceuticals Ltd., Translational Biomarkers, Allschwil, 4123, Switzerland., Jasnowski R; Active Biomarkers, 60F Avenue Rockefeller, Lyon, 69008, France., Justies N; Roche Innovation Center Basel, Roche Pharmaceutical Research & Early Development, Basel, 4070, Switzerland., Kimberg M; Synexa Life Sciences BV, Leiden, 2333 CS, The Netherlands., Kunz U; Boehringer Ingelheim Pharma GmbH & Co. KG, Translational Medicine & Clinical Pharmacology, Biberach an der Riss, 88397, Germany., Lawrence J; F-star Therapeutics, Cambridge, CB22 3AT, UK., Richter M; AbbVie Deutschland GmbH & Co KG, DMPK-BA, Knollstrasse, Ludwigshafen, 67061, Germany., Sordé L; Sobi AG, Bioanalytical Sciences, Plan-les-Ouates, 1228, Switzerland., Trigt RV; ICON Bioanalytical Laboratories, Assen, 9407 TK, The Netherlands., Vermet L; Sanofi Research & Development, Translational Medicine & Early Development, Biomarkers & Clinical Bioanalysis, Montpellier, 34080, France., Vitaliti A; Novartis Institutes for Biomedical Research, Novartis Pharma AG, Basel, 4056, Switzerland., Wright M; GlaxoSmithKline, Bioanalysis Immunogenicity & Biomarkers, Stevenage, SG1 2NY, UK., Timmerman P; European Bioanalysis Forum, Brussels, 1000, Belgium.

المصدر: Bioanalysis [Bioanalysis] 2022 Jul; Vol. 14 (13), pp. 911-917. Date of Electronic Publication: 2022 Jul 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Future Science Country of Publication: England NLM ID: 101512484 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-6199 (Electronic) Linking ISSN: 17576180 NLM ISO Abbreviation: Bioanalysis Subsets: MEDLINE

مواضيع طبية MeSH: Biological Assay*, Biomarkers/analysis

PDF full text from Publisher

6

دورية أكاديمية

EBF recommendation on practical management of critical reagents for PK ligand-binding assays.

المؤلفون: Pihl S; Susanne Pihl, Ascendis Pharma A/S, Copenhagen, Denmark., van der Strate BW; PRA Health Sciences, Assen, The Netherlands., Golob M; Nuvisan GmbH, Grafing, Germany., Vermet L; Sanofi Research & Development, Montpellier, France., Jaitner B; Novartis Pharma AG, Basel, Switzerland., Goodman J; MedImmune, Cambridge, UK., Fjording MS; Novo Nordisk A/S, Måløv, Denmark., Timmerman P; European Bioanalysis Forum, Havenlaan 86c b204, 1000 Brussels, Belgium.

المصدر: Bioanalysis [Bioanalysis] 2018 Oct 01; Vol. 10 (19), pp. 1557-1565. Date of Electronic Publication: 2018 Sep 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Future Science Country of Publication: England NLM ID: 101512484 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-6199 (Electronic) Linking ISSN: 17576180 NLM ISO Abbreviation: Bioanalysis Subsets: MEDLINE

مواضيع طبية MeSH: Indicators and Reagents/*pharmacokinetics, Documentation ; Europe ; Guidelines as Topic ; Indicators and Reagents/metabolism ; Ligands ; Social Control, Formal

PDF full text from Publisher

7

دورية أكاديمية

Toward decision-based acceptance criteria for Bioanalytical Method Validation: a proposal for discussion from the European Bioanalysis Forum.

المؤلفون: Timmerman P; European Bioanalysis Forum, Havenlaan 86c b204, 1000 Brussels, Belgium., Golob M; Nuvisan, Grafing, Germany., Goodman J; MedImmune, Cambridge, UK., Knutsson M; Ferring, Copenhagen, Denmark., Nelson R; Novimmune, Geneva, Switzerland., Fjording MS; Novo Nordisk, Måløv, Denmark., White S; GlaxoSmithKline, Ware, UK.

المصدر: Bioanalysis [Bioanalysis] 2018 Aug 01; Vol. 10 (16), pp. 1255-1259. Date of Electronic Publication: 2018 Aug 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Future Science Country of Publication: England NLM ID: 101512484 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-6199 (Electronic) Linking ISSN: 17576180 NLM ISO Abbreviation: Bioanalysis Subsets: MEDLINE

مواضيع طبية MeSH: Chemistry Techniques, Analytical* , Decision Making*, Europe ; Reproducibility of Results

PDF full text from Publisher

8

Feedback from the European Bioanalysis Forum: focus workshop on current analysis of immunogenicity: best practices and regulatory hurdles.

المؤلفون: Goodman J; MedImmune, Aaron Klug Building, Granta Park, Cambridge, Cambridgeshire, CB21 6GH, UK, +44 (0) 203 749 6244, +44 (0) 1223 471472., Cowen S; LGC, Queens Road, Teddington, Middlesex TW11 0LY, UK., Devanarayan V; Charles River Laboratories, 905 Sheehy Dr, Horsham, PA 19044; formerly located at Abbvie during the production of this manuscript., Egging D; Synthon, Microweg 22, P.O. Box 7071, 6503 GN Nijmegen, The Netherlands., Emrich T; Roche Pharma Research & Early Development, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany., Golob M; Nuvisan GmbH, Am Feld 32, 85567 Grafing, Germany., Kramer D; Sanofi Aventis Deutschland GmbH, Industriepark Höchst, D-Frankfurt am Main, Germany., McNally J; Shire, 300 Shire Way, Lexington MA 02421; formerly located at Merck Serono during production of this manuscript., Munday J; Covance Laboratories Ltd, Otley Road, Harrogate, HG31PY, United Kingdom., Nelson R; Novimmune SA, 14 Chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland., Pedras-Vasconcelos JA; US Food and Drug Administration/Center for Drugs Evaluation and Research/Office of Biotechnology Products/Division of Biotech Review and Research 3, MD, USA., Piironen T; Syrinx Bioanalytics, Pansiontie 47, Biohouse D5, 20210 Turku, Finland., Sickert D; Novartis, Kohlenstrasse, WSJ-386.13.05.14, CH-4056 Basel, Switzerland., Skibeli V; Norwegian Medicines Agency, Stroemsveien 96, Postboks 6167 Etterstad, 0602 Oslo, Norway., Fjording MS; Novo Nordisk A/S, Novo Nordisk Park, DK-2760 Måløv, Denmark., Timmerman P; European Bioanalysis Forum, Havenlaan 86c b204, 1000 Brussels, Belgium.

المصدر: Bioanalysis [Bioanalysis] 2018 Feb; Vol. 10 (4), pp. 197-204. Date of Electronic Publication: 2018 Jan 18.

نوع المنشور: Congress

بيانات الدورية: Publisher: Future Science Country of Publication: England NLM ID: 101512484 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-6199 (Electronic) Linking ISSN: 17576180 NLM ISO Abbreviation: Bioanalysis Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Neutralizing/*analysis , Biological Products/*immunology , Drug Tolerance/*immunology , Immunoassay/*standards, Biological Products/therapeutic use ; Drug Discovery ; Guidelines as Topic ; Humans

PDF full text from Publisher

9

دورية أكاديمية

C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid.

المؤلفون: Hornum L; Novo Nordisk A/S, Måløv, Denmark., Hansen AJ; Novo Nordisk A/S, Måløv, Denmark., Tornehave D; Novo Nordisk A/S, Måløv, Denmark., Fjording MS; Novo Nordisk A/S, Måløv, Denmark., Colmenero P; Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom., Wätjen IF; The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Frederiksberg, Denmark., Søe Nielsen NH; Hand Section, Department of Orthopaedics, Herlev and Gentofte Hospital, Gentofte, Denmark., Bliddal H; The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Frederiksberg, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Bartels EM; The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Frederiksberg, Denmark.

المصدر: PloS one [PLoS One] 2017 Dec 08; Vol. 12 (12), pp. e0189017. Date of Electronic Publication: 2017 Dec 08 (Print Publication: 2017).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Chemotaxis, Leukocyte*, Arthritis, Psoriatic/*metabolism , Arthritis, Rheumatoid/*metabolism , Complement C5a/*metabolism , Leukocytes/*pathology , Receptor, Anaphylatoxin C5a/*metabolism , Synovial Fluid/*metabolism, Enzyme-Linked Immunosorbent Assay ; Flow Cytometry ; Humans ; Immunohistochemistry

Find this article in full text from ProQuest

Full Text Finder

10

دورية أكاديمية

2017 White Paper on recent issues in bioanalysis: a global perspective on immunogenicity guidelines & biomarker assay performance (Part 3 - LBA: immunogenicity, biomarkers and PK assays).

المؤلفون: Gupta S; Amgen, Thousand Oaks, CA, USA., Richards S; Sanofi, Framingham, MA, USA., Amaravadi L; Sanofi, Framingham, MA, USA., Piccoli S; Neoteric, Princeton, NJ, USA., Desilva B; Bristol-Myers Squibb, Princeton, NJ, USA., Pillutla R; Bristol-Myers Squibb, Princeton, NJ, USA., Stevenson L; Biogen, Cambridge, MA, USA., Mehta D; Biogen, Cambridge, MA, USA., Carrasco-Triguero M; Genentech, South San Francisco, CA, USA., Neely R; Bristol-Myers Squibb, Princeton, NJ, USA., Partridge M; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Staack RF; Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany., Zhao X; Merck, Rahway, NJ, USA., Gorovits B; Pfizer, Andover, MA, USA., Kolaitis G; Bristol-Myers Squibb, Princeton, NJ, USA., Sumner G; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Stubenrauch KG; Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany., Zou L; Teva Pharmaceuticals, West Chester, PA, USA., Amur S; US FDA, Silver Spring, MD, USA., Beaver C; InVentiv Health, Montreal, QC, Canada., Berger I; Austria AGES, Wien, Austria., Berisha F; Daiichi Sankyo, Edison, NJ, USA., Birnboeck H; Roche Pharma Research & Early Development, Roche Innovation Center, Basel, Switzerland., Bower J; Covance, Chantilly, VA, USA., Cho SJ; US FDA, Silver Spring, MD, USA., Cludts I; UK MHRA-NIBSC, London, UK., Cocea L; Health Canada, Ottawa, ON, Canada., Donato LD; Caprion Biosciences, Montreal, QC, Canada., Fischer S; Genentech, South San Francisco, CA, USA., Fraser S; Pfizer, Groton, CT, USA., Garofolo F; Angelini Pharma, Pomezia, RM, Italy., Haidar S; US FDA, Silver Spring, MD, USA., Haulenbeek J; Bristol-Myers Squibb, Princeton, NJ, USA., Hottenstein C; GlaxoSmithKline, King of Prussia, PA, USA., Hu J; Amgen, Thousand Oaks, CA, USA., Ishii-Watabe A; Japan MHLW-NIHS, Tokyo, Japan., Islam R; Celerion, Lincoln, NE, USA., Jani D; Pfizer, Andover, MA, USA., Kadavil J; US FDA, Silver Spring, MD, USA., Kamerud J; Eurofins Bioanalytical Services, St Charles, MO, USA., Kramer D; Sanofi, Frankfurt am Main, Germany., Kurki P; Finland Fimea, Helsinki, Finland., MacMannis S; Pfizer, Groton, CT, USA., McNally J; EMD Serono, Billerica, MA, USA., Mullan A; MedImmune, Mount Airy, MD, USA., Papadimitriou A; Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany., Pedras-Vasconcelos J; US FDA, Silver Spring, MD, USA., Ray S; Vertex Pharmaceuticals, Boston, MA, USA., Safavi A; Bioagilytix Labs, Durham, NC, USA., Saito Y; Japan MHLW-NIHS, Tokyo, Japan., Savoie N; CFABS, Laval, QC, Canada., Fjording MS; Novo Nordisk, Maaloev, Denmark., Scheibner K; US FDA, Silver Spring, MD, USA., Smeraglia J; UCB Biopharma, Braine L'Alleud, Belgium., Song A; Genentech, South San Francisco, CA, USA., Stouffer B; PPD, Richmond, VA, USA., Tampal N; US FDA, Silver Spring, MD, USA., der Strate BV; PRA Health Sciences, Assen, The Netherlands., Verch T; Merck, West Point, PA, USA., Welink J; Dutch MEB, Utrecht, The Netherlands., Xu Y; Alnylam Pharmaceuticals, Cambridge, MA, USA., Yang TY; Janssen R&D, Spring House, PA, USA., Yengi L; Bluebirdbio, Cambridge, MA, USA., Zeng J; Bristol-Myers Squibb, Princeton, NJ, USA., Zhang Y; Bristol-Myers Squibb, Princeton, NJ, USA., Zhang Y; Pfizer, Groton, CT, USA., Zoog S; BioMarin Pharmaceutical, San Rafael, CA, USA.

المصدر: Bioanalysis [Bioanalysis] 2017 Dec; Vol. 9 (24), pp. 1967-1996. Date of Electronic Publication: 2017 Dec 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Future Science Country of Publication: England NLM ID: 101512484 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-6199 (Electronic) Linking ISSN: 17576180 NLM ISO Abbreviation: Bioanalysis Subsets: MEDLINE

مواضيع طبية MeSH: Immunity, Active*, Biomarkers/*analysis, Chromatography, Liquid ; Consensus Development Conferences as Topic ; Drug Tolerance ; Guidelines as Topic ; Ligands ; Mass Spectrometry ; Pharmacokinetics

PDF full text from Publisher

تنقيح النتائج